Autologous vs. Allogenic Stem Cell Transplants: What’s the Difference?

A stem cell transplant is a procedure during which doctors either replace diseased or ineffective stem cells with healthy new stem cells or allow high-dose treatment for lymphoma, some testicular cancers, and other diseases. It is often lifesaving for patients with blood cancer and serious blood disorders.

A person may need a transplant for a few different reasons: when their body cannot make the blood cells that it needs, because their bone marrow or blood cells have become diseased and need to be replaced, or because they have a disease that is treated with high doses of chemotherapy and/or radiation, which destroys cancerous and stem cells at the same time.

Two of the most common types of stem cell transplants are autologous and allogeneic transplants. Both kinds of stem cell transplantations are a common treatment option for cancers such as leukemia, lymphoma, and multiple myeloma.

An autologous transplant uses a person’s own stem cells. In this procedure, stem cells are collected from the patient and frozen in liquid nitrogen before transplant conditioning. Stem cells are intrinsically normal, and they are collected to allow blood cell recovery after the administration of high dose therapy that would otherwise irreversibly damage them. Following conditioning treatment, the patient’s stem cells are returned to the body to help it produce healthy red and white blood cells and platelets.

An allogeneic stem cell transplant uses stem cells from a donor whose human leukocyte antigens (HLA) are acceptable matches to the patient’s. The stem cell donor may be related to the patient, or they may be an unrelated volunteer found through a donor registry search such as the National Marrow Donor Program.

There are two types of allogeneic transplants. In a myeloablative transplant, large doses of chemotherapy – or a combination of chemotherapy and radiation – are used to overcome resistance and eradicate a patient’s malignancy. In a reduced-intensity allogeneic transplant, doctors suppress the recipient’s immune system enough so the donor stem cells can take root, or “engraft,” there. The intensity of the therapy is insufficient to eradicate the malignancy, so this form of transplantation depends on the immunologic recognition of the cancer by the immune system of the donor. This is called the graft-versus-tumor effect.

These types of transplants are also used to treat blood disorders and immune system diseases, such as aplastic anemia, sickle cell anemia, myelodysplastic syndromes, Waldenström’s macroglobulinemia, and myeloproliferative disorders. Which type of transplant is appropriate for a patient is determined by his or her transplant physician.

The process of growing new blood cells after receiving a transplant generally takes between two and four weeks. But because stem cell transplants destroy and rebuild the immune system, patients are left immunocompromised and more vulnerable to infection from common germs and fungi. The full recovery of the immune system can take much longer. It’s important to ensure that your home is ready for a safe return after the procedure, and to follow your care team’s directions regarding visitor and food restrictions, which are designed to limit your risk of complications.

Make An Appointment

For adults: 877-442-9599

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Follow Dana-Farber's @DrHBurstein & @DrChoueiri for all the latest updates from #ASCO17 next week! https://t.co/VgvnHAjGvt
Dana-Farber @danafarber
Watch: Doctors & patients share the promise of #immunotherapy at this year's Susan F. Smith Center for Breakfast: https://t.co/XTWdgtvaju
Dana-Farber @danafarber
New Online Tool Guides Genetic Testing for #LynchSyndrome: https://t.co/KTCLvyHAmg https://t.co/rxFPs5lX71

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.